In8Bio Inc (INAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,689 | 13,226 | 11,888 | 11,120 | 4,001 |
| TOTAL | $11,768 | $13,741 | $12,725 | $12,578 | $6,703 |
| Non-Current Assets | |||||
| PPE Net | 2,103 | 2,347 | 2,602 | 2,858 | 3,081 |
| Other Non-Current Assets | 2,897 | 3,283 | 4,542 | 5,508 | 6,182 |
| TOTAL | $5,000 | $5,630 | $7,144 | $8,366 | $9,263 |
| Total Assets | $16,768 | $19,371 | $19,869 | $20,944 | $15,966 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 204 | 379 | 575 | 389 | 1,137 |
| Accrued Expenses | 418 | 635 | 1,145 | 1,047 | 769 |
| TOTAL | $1,703 | $1,954 | $2,957 | $3,083 | $3,635 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,812 | 2,052 | 2,846 | 3,088 | 3,344 |
| TOTAL | $1,876 | $2,178 | $3,035 | $3,383 | $3,743 |
| Total Liabilities | $3,579 | $4,132 | $5,992 | $6,466 | $7,378 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,634 | 4,540 | 3,023 | 2,706 | 2,414 |
| Common Shares | 10 | 10 | 8 | 7 | 5 |
| Retained earnings | -136,154 | -132,300 | -127,206 | -121,656 | -115,496 |
| TOTAL | $13,189 | $15,239 | $13,877 | $14,478 | $8,588 |
| Total Liabilities And Equity | $16,768 | $19,371 | $19,869 | $20,944 | $15,966 |